#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired C1 inhibitor deficiency B-cell lymphoma Leiomyosarcoma Spinal muscular atrophy Neurotrophic keratopathy General anaesthesia Neuroblastoma Polycythaemia vera Pustular psoriasis Bronchopulmonary aspergillosis Leukocyte adhesion deficiency Alagille syndrome Congenital cystic kidney disease Chronic lymphocytic leukaemia Thymic carcinoma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Trials in Disease Piriformis syndrome – Diagnostics Congenital nephrogenic diabetes insipidus – Diagnostics Gastrointestinal stromal tumour Synovial sarcoma recurrent – Trials in Disease Pulmonary sarcoidosis – Basic Information Breast angiosarcoma – Treatment Primary hyperoxaluria – Basic Information Nodal marginal zone B-cell lymphoma – Life with Disease Nephroblastoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azacitidine RUBIDIUM CHLORIDE Human Coagulation Factor X Clofarabine Demeclocycline Hydrochloride ACT-1004-1239 Phosphocreatine Sodium Clemizole Hydrochloride Lutropin Alfa Tafluprost Gad20-209-Fsp-A1 Leuprorelin Hydrocortisone Acetate Fluorouracil Sodium L-Lysine Hydrochloride Avalotcagene Ontaparvovec Tramazoline Hydrochloride Disitamab Vedotin REGN7544 Aluminium Hydroxide More therapies…

    Learn about Your Condition

    Pulmonary embolism Nephrotic syndrome Parkinson's disease Infectious pleural effusion Gastric cancer stage IV Allergic respiratory disease Traumatic pain Heart transplant Venous thrombosis limb HER2 positive breast cancer Procedural pain Clinically isolated syndrome Corneal dystrophy Rhabdoid tumour of the kidney Pancreatic fistula More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-Hodgkin’s lymphoma unspecified histology aggressive recurrent

  • Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Odronextamab
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Germany Hungary Italy +4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!